IRadimed (IRMD) Revenue & Revenue Breakdown

OverviewOwnership Financials Chart Transcripts

IRadimed Revenue Highlights

Latest Revenue (Y)

$83.81M

Latest Revenue (Q)

$21.98M

Main Segment (Y)

MRI Compatible Patient Vital Signs Monitoring Systems

Main Geography (Y)

UNITED STATES

IRadimed Revenue by Period

IRadimed Revenue by Year

Date	Revenue	Change
2025-12-31	$83.81M	14.43%
2024-12-31	$73.24M	11.71%
2023-12-31	$65.56M	23.00%
2022-12-31	$53.30M	27.48%
2021-12-31	$41.81M	31.83%
2020-12-31	$31.72M	-17.65%
2019-12-31	$38.52M	26.54%
2018-12-31	$30.44M	31.88%
2017-12-31	$23.08M	-28.97%
2016-12-31	$32.50M	2.86%
2015-12-31	$31.59M	101.84%
2014-12-31	$15.65M	38.03%
2013-12-31	$11.34M	47.56%
2012-12-31	$7.69M	-

IRadimed generated $83.81M in revenue during NA 2025, up 14.43% compared to the previous quarter, and up 264.25% compared to the same period a year ago.

IRadimed Revenue by Quarter

Date	Revenue	Change
2026-03-31	$21.98M	-3.14%
2025-12-31	$22.69M	7.03%
2025-09-30	$21.20M	3.88%
2025-06-30	$20.41M	4.61%
2025-03-31	$19.51M	0.63%
2024-12-31	$19.39M	5.80%
2024-09-30	$18.33M	2.21%
2024-06-30	$17.93M	1.88%
2024-03-31	$17.60M	0.84%
2023-12-31	$17.45M	5.74%
2023-09-30	$16.50M	2.32%
2023-06-30	$16.13M	4.23%
2023-03-31	$15.48M	4.11%
2022-12-31	$14.86M	10.86%
2022-09-30	$13.41M	5.39%
2022-06-30	$12.72M	3.34%
2022-03-31	$12.31M	3.69%
2021-12-31	$11.87M	8.85%
2021-09-30	$10.91M	11.18%
2021-06-30	$9.81M	6.36%
2021-03-31	$9.22M	7.93%
2020-12-31	$8.55M	11.00%
2020-09-30	$7.70M	13.31%
2020-06-30	$6.79M	-21.70%
2020-03-31	$8.68M	-20.32%
2019-12-31	$10.89M	9.31%
2019-09-30	$9.96M	8.00%
2019-06-30	$9.23M	9.34%
2019-03-31	$8.44M	1.18%
2018-12-31	$8.34M	9.52%
2018-09-30	$7.61M	3.22%
2018-06-30	$7.38M	3.78%
2018-03-31	$7.11M	6.01%
2017-12-31	$6.70M	17.84%
2017-09-30	$5.69M	2.99%
2017-06-30	$5.52M	7.01%
2017-03-31	$5.16M	-13.82%
2016-12-31	$5.99M	-21.93%
2016-09-30	$7.67M	-22.25%
2016-06-30	$9.87M	10.09%
2016-03-31	$8.96M	1.87%
2015-12-31	$8.80M	7.39%
2015-09-30	$8.19M	7.68%
2015-06-30	$7.61M	8.83%
2015-03-31	$6.99M	95.11%
2014-12-31	$3.58M	-5.99%
2014-09-30	$3.81M	-18.90%
2014-06-30	$4.70M	32.14%
2014-03-31	$3.56M	2.90%
2013-12-31	$3.46M	39.41%
2013-09-30	$2.48M	-10.64%
2013-06-30	$2.78M	5.58%
2013-03-31	$2.63M	-

IRadimed generated $21.98M in revenue during Q1 2026, up -3.14% compared to the previous quarter, and up 113.36% compared to the same period a year ago.

IRadimed Revenue Breakdown

IRadimed Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
MRI Compatible Patient Vital Signs Monitoring Systems	$26.43M	$24.41M	$25.41M	$21.72M	-
MRI compatible patient vital signs monitoring systems	-	-	-	-	$13.78M
MRI compatible IV infusion pump system	-	-	-	-	$13.29M

IRadimed's latest annual revenue breakdown by segment (product or service), as of Dec 25: MRI Compatible Patient Vital Signs Monitoring Systems (100.00%).

Quarterly Revenue by Product

Product/Service	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
Service	$1.04M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Device Revenue	$15.39M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
MRI Compatible Patient Vital Signs Monitoring Systems	$7.11M	$7.07M	$6.87M	$5.94M	$6.54M	$6.57M	$5.93M	$5.45M	$6.46M	$14.59M	$6.13M	$4.70M	$6.09M	$5.52M	-	-	-	-	-	-
MRI compatible patient vital signs monitoring systems	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$4.92M	$5.19M	$4.02M	-	-	-
MRI compatible IV infusion pump system	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$3.85M	$3.28M	$3.96M	-	-	-
M R I Compatible I V Infusion Pumps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$3.37M	$2.46M	$3.50M
M R I Compatible Patient Vital Signs Monitoring Systems	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$3.78M	$3.38M	-
Mri Compatible Patient Vital Signs Monitoring Systems	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$2.60M

IRadimed's latest quarterly revenue breakdown by segment (product or service), as of Mar 26: Device Revenue (65.38%), MRI Compatible Patient Vital Signs Monitoring Systems (30.19%), and Service (4.43%).

IRadimed Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
International	$13.26M	$12.64M	$13.04M	-	-
UNITED STATES	$70.56M	$60.61M	$52.53M	$43.90M	-
United States	-	-	-	-	$33.46M

IRadimed's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (84.18%), and International (15.82%).

Quarterly Revenue by Country

Country	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
UNITED STATES	$18.02M	$18.30M	$18.11M	$18.19M	$15.95M	$16.51M	$15.21M	$15.49M	$13.41M	$27.60M	$12.95M	$11.98M	$12.29M	-	-	-	-	-	-	-
Non-US	$3.95M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
International	-	$4.39M	$3.09M	$2.22M	$3.56M	$2.88M	$3.12M	$2.44M	$4.19M	-	-	-	-	-	-	-	-	-	-	-
United States	-	-	-	-	-	-	-	-	-	-	-	-	-	$10.81M	$10.82M	$9.98M	$9.47M	-	-	-
U	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$8.68M	$8.04M	$7.27M

IRadimed's latest quarterly revenue breakdown by geography, as of Mar 26: UNITED STATES (82.01%), and Non-US (17.99%).

IRadimed Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
AHCO	AdaptHealth	$3.24B	$819.80M
IART	Integra LifeSciences	$1.64B	$391.92M
TNDM	Tandem Diabetes Care	$1.01B	$247.22M
CTEV	Claritev	$965.41M	$244.68M
GDRX	GoodRx	$792.32M	$196.03M
OPK	OPKO Health	$606.89M	$124.20M
INMD	InMode	$492.05M	$80.28M
MDXG	MiMedx Group	$418.63M	$58.99M
AXGN	AxoGen	$225.21M	$61.46M
CRON	Cronos Group	$193.36M	$58.97M
IRMD	IRadimed	$83.81M	$21.98M

IRMD Revenue FAQ

What is IRadimed’s yearly revenue?

IRadimed's yearly revenue for 2025 was $83.81M, representing an increase of 14.43% compared to 2024. The company's yearly revenue for 2024 was $73.24M, representing an increase of 11.71% compared to 2023. IRMD's yearly revenue for 2023 was $65.56M, representing an increase of 23.00% compared to 2022.

What is IRadimed’s quarterly revenue?

IRadimed's quarterly revenue for Q1 2026 was $21.98M, a -3.14% decrease from the previous quarter (Q4 2025), and a 12.65% increase year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $22.69M, a 7.03% increase from the previous quarter (Q3 2025), and a 17.03% increase year-over-year (Q4 2024). IRMD's quarterly revenue for Q3 2025 was $21.2M, a 3.88% increase from the previous quarter (Q2 2025), and a 15.69% increase year-over-year (Q3 2024).

What is IRadimed’s revenue growth rate?

IRadimed's revenue growth rate for the last 3 years (2023-2025) was 27.84%, and for the last 5 years (2021-2025) was 100.44%.

What are IRadimed’s revenue streams?

IRadimed's revenue streams in c 25 are MRI Compatible Patient Vital Signs Monitoring Systems

What is IRadimed’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of IRadimed was MRI Compatible Patient Vital Signs Monitoring Systems. This segment made a revenue of $26.43M, representing 100.00% of the company's total revenue.